These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1703358)

  • 1. Measurement of FK 506 by HPLC and isolation and characterization of its metabolites.
    Christians U; Kruse C; Kownatzki R; Schiebel HM; Schwinzer R; Sattler M; Schottmann R; Linck A; Almeida VM; Braun F
    Transplant Proc; 1991 Feb; 23(1 Pt 2):940-1. PubMed ID: 1703358
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of murine B-lymphocyte proliferation by the novel immunosuppressive drug FK-506.
    Walliser P; Benzie CR; Kay JE
    Immunology; 1989 Nov; 68(3):434-5. PubMed ID: 2480331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of action of FK 506.
    Kay JE; Moore AL; Doe SE; Benzie CR; Schönbrunner R; Schmid FX; Halestrap AP
    Transplant Proc; 1990 Feb; 22(1):96-9. PubMed ID: 1689914
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of FK 506 on B-cell responses.
    Lagodziński Z; Górski A; Stepień-Sopniewska B; Wasik M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):942-3. PubMed ID: 1703359
    [No Abstract]   [Full Text] [Related]  

  • 5. Interspecies comparison of the immunosuppressive efficacy and safety of FK 506.
    Thomson AW
    Transplant Proc; 1990 Feb; 22(1):100-5. PubMed ID: 1689883
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation.
    Wu J; Palladino MA; Figari IS; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):238-40. PubMed ID: 1703683
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of T and B lymphocyte proliferation by rapamycin.
    Kay JE; Kromwel L; Doe SE; Denyer M
    Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transduction. Immunosuppressants at work.
    DeFranco AL
    Nature; 1991 Aug; 352(6338):754-5. PubMed ID: 1715515
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolation of an immunosuppressive metabolite of FK506 generated by human microsome preparations.
    Christians U; Radeke HH; Kownatzki R; Schiebel HM; Schottmann R; Sewing KF
    Clin Biochem; 1991 Jun; 24(3):271-5. PubMed ID: 1714802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FK-506 related compounds produced by Streptomyces tsukubaensis No. 9993.
    Hatanaka H; Kino T; Asano M; Goto T; Tanaka H; Okuhara M
    J Antibiot (Tokyo); 1989 Apr; 42(4):620-2. PubMed ID: 2470720
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.
    Kay JE; Benzie CR; Goodier MR; Wick CJ; Doe SE
    Immunology; 1989 Aug; 67(4):473-7. PubMed ID: 2475433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial transformation of immunosuppressive compounds. II. Specific desmethylation of 13-methoxy group of FK 506 and FR 900520 by an unidentified Actinomycete ATCC 53828 [corrected].
    Chen TS; Arison BH; Wicker LS; Inamine ES
    J Antibiot (Tokyo); 1992 Apr; 45(4):577-80. PubMed ID: 1375593
    [No Abstract]   [Full Text] [Related]  

  • 13. FK 506 and rapamycin: molecular probes of T-lymphocyte activation.
    Bierer BE; Jin YJ; Fruman DA; Calvo V; Burakoff SJ
    Transplant Proc; 1991 Dec; 23(6):2850-5. PubMed ID: 1721296
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro immunosuppressive activity, isolation from pig liver microsomes and identification by electrospray ms-ms of a new FK-506 C19-C20 epoxide metabolite.
    Lhoëst G; Dieden R; Verbeeck RK; Maton N; Ingendoh A; Latinne D
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1074-81. PubMed ID: 9495869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human T-cell activation by FK 506, rapamycin, and cyclosporine A.
    Sigal NH; Lin CS; Siekierka JJ
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):1-5. PubMed ID: 1712132
    [No Abstract]   [Full Text] [Related]  

  • 16. Isolation and mass spectrometric identification of five metabolites of FK-506, a novel macrolide immunosuppressive agent, from human plasma.
    Lhoëst G; Wallemacq P; Verbeeck R
    Pharm Acta Helv; 1991; 66(11):302-6. PubMed ID: 1722046
    [No Abstract]   [Full Text] [Related]  

  • 17. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.
    Siekierka JJ; Hung SH; Poe M; Lin CS; Sigal NH
    Nature; 1989 Oct; 341(6244):755-7. PubMed ID: 2477714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of the major equilibrium product of FK-520.
    Gailliot FP; Natishan TK; Ballard JM; Reamer RA; Kuczynski D; Mcmanemin GJ; Egan RS; Buckland BC
    J Antibiot (Tokyo); 1994 Jul; 47(7):806-11. PubMed ID: 7520900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observations on the mechanism of action of FK-506. A pharmacologic probe of lymphocyte signal transduction.
    Sigal NH; Siekierka JJ; Dumont FJ
    Biochem Pharmacol; 1990 Nov; 40(10):2201-8. PubMed ID: 1700909
    [No Abstract]   [Full Text] [Related]  

  • 20. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.
    de Paulis A; Cirillo R; Ciccarelli A; Condorelli M; Marone G
    J Immunol; 1991 Apr; 146(7):2374-81. PubMed ID: 1706398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.